Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

ClinicalTrials.gov ID: NCT03253263

Public ClinicalTrials.gov record NCT03253263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.

Study identification

NCT ID
NCT03253263
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
OHB Neonatology Ltd.
Industry
Enrollment
295 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Hours to 24 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2019
Primary completion
Jul 30, 2026
Completion
Jan 20, 2028
Last update posted
Aug 2, 2026

2019 – 2028

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202-3500
University of Arkansas for Medical Sciences Little Rock Arkansas 72202-3500
Children's Hospital of Orange County California City California 92868
Cedars Sinai Medical Center Los Angeles California 90048
US Davis Sacramento California 95817
Jackson Memorial Hospital Miami Florida 33136-1005
Tampa General Hospital Tampa Florida 33606-3571
University of Illinois at Chicago Chicago Illinois 60612
Riley Hospital for Children Indianapolis Indiana 46202
Memorial Hospital of South Bend South Bend Indiana 46601-1078
University of Louisville Hospital Louisville Kentucky 40202
Ochsner Baptist Medical Center New Orleans Louisiana 70115
Tufts Medical Center Boston Massachusetts 02111-1553
Children's Minnesota - Children's Hospital and Clinics - St. Paul Saint Paul Minnesota 55102
Children's Minnesota - Children's Hospital and Clinics Saint Paul Minnesota 55102
University of Mississippi Medical Center Jackson Mississippi 39216-4500
University of Rochester Rochester New York 14627
Maria Fareri Children's Hospital Valhalla New York 10595
Oklahoma Children's Hospital - PIN Oklahoma City Oklahoma 73104
Medical University of South Carolina Children Hospital Charleston South Carolina 29425-8908
Texas Children's Hospital Houston Texas 77030
UT Health Science Center San Antonio Texas 78229
UVA Children's Hospital Charlottesville Virginia 22903
Virginia Commonwealth University - Children's Hospital of Richmond at VCU Richmond Virginia 23298-5075

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03253263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2026 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03253263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →